Prescription drug pricing
Subtitle: implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives
By: United States General Accounting Office.
Contributors: United States. General Accounting Office.; United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.
Series: Testimony -- GAO/T-HEHS-96-216.
Publisher: The Office; The Office [distributor
Published: 1996
Place of publication: Washington, D.C; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015)
Language: eng
Subjects: Prescription pricing -- United States.; Drugs -- Prices -- United States.; Drugstores -- United States.
Other titles: Implications for retail pharmacies.
Notes: Not distributed to depository libraries in a physical form.

"September 19, 1996."

Includes bibliographical references.

Available via Internet from the GPO Access web site. Address as of 5/21/2001: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:he96216t.pdf; current access is available via PURL.